Enoxaparin is noninferior to unfractionated heparin in patients with non-ST elevation acute coronary syndrome treated with the use of early invasive strategy.: Results of SYNERGY Trial

被引：0
|
作者：
Gratsianskii, NA
机构：
来源：
KARDIOLOGIYA | 2004年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：77 / 79
页数：3
相关论文
共 50 条
  • [31] A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: Enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes
    Cohen, Marc
    Mahaffey, Kenneth W.
    Pieper, Karen
    Pollack, Charles V.
    Antman, Elliott M.
    Hoekstra, James
    Goodman, Shaun G.
    Langer, Anatoly
    Col, Jacques J.
    White, Harvey D.
    Califf, Robert M.
    Ferguson, James J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) : 1346 - 1354
  • [32] Non-ST elevation acute coronary syndrome: changes of parameters of Hemostasis during and after treatment with unfractionated and low molecular (enoxaparin) heparins
    Averkov, OV
    Slavina, NN
    Dobrovolsky, AB
    Gratsiansky, NA
    KARDIOLOGIYA, 2003, 43 (09) : 28 - 40
  • [33] Long-term prognosis of chronic kidney disease in non-ST elevation acute coronary syndrome treated with invasive strategy
    Roldan Torres, Ildefonso
    Salvador Mercader, Inmaculada
    Cabades Rumbeu, Claudia
    Diez Gil, Jose Luis
    Ferrando Cervello, Jose
    Monteagudo Viana, Marta
    Fernandez Galera, Ruben
    Mora Llabata, Vicente
    NEFROLOGIA, 2017, 37 (03): : 276 - 284
  • [34] The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients
    Khalill, Ramjane
    Han, Lei
    Jing, Chang
    Quan, He
    EXPERIMENTAL & CLINICAL CARDIOLOGY, 2009, 14 (02) : E25 - E30
  • [35] Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
    White, Harvey D.
    Kleiman, Neal S.
    Mahaffey, Kenneth W.
    Lokhnygina, Yuliya
    Pieper, Karen S.
    Chiswell, Karen
    Cohen, Marc
    Harrington, Robert A.
    Chew, Derek P.
    Petersen, John L.
    Berdan, Lisa G.
    Aylward, Philip E. G.
    Nessel, Christopher C.
    Ferguson, James J., III
    Califf, Robert M.
    AMERICAN HEART JOURNAL, 2006, 152 (06) : 1042 - 1050
  • [36] Myocardial edema in patients with non-ST elevation acute coronary syndrome predicts coronary revascularization strategy
    Winner, Marshall W., III
    Dickerson, Jennifer
    Ballinger, Michelle
    Simonetti, Orlando
    Ambrosio, Giuseppe
    Mazzaferri, Ernest, Jr.
    Raman, Subha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A164 - A165
  • [37] A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes
    Califf, RM
    Petersen, JL
    Hasselblad, V
    Mahaffey, KW
    Ferguson, JJ
    AMERICAN HEART JOURNAL, 2005, 149 (04) : S91 - S99
  • [38] OCT Analysis of Very Early Strut Coverage of the Synergy Stent in Non-ST Segment Elevation Acute Coronary Syndrome Patients
    Laine, Marc
    Dabry, Thibaut
    Combaret, Nicolas
    Motreff, Pascal
    Puymirat, Etienne
    Paganelli, Franck
    Thuny, Franck
    Cautela, Jennifer
    Peyrol, Michael
    Mancini, Julien
    Lemesle, Gilles
    Bonello, Laurent
    JOURNAL OF INVASIVE CARDIOLOGY, 2019, 31 (01): : 10 - 14
  • [39] Prognostic impact of heparin crossover across the spectrum of non-ST elevation acute coronary syndrome patients
    Tralhao, A.
    Sousa, P.
    Raposo, L.
    Goncalves, P.
    Gabriel, H. M.
    Almeida, M.
    Teles, R. C.
    Brito, J.
    Leal, S.
    Mendes, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 146 - 146
  • [40] Comments on predictors of the use of the early invasive strategy in women with non-ST-elevation acute coronary syndrome
    Alquezar Arbe, A.
    Trejo Gutierrez, O.
    Turbau Valls, M.
    Barcons Pujol, M.
    MEDICINA INTENSIVA, 2015, 39 (03) : 196 - 197
12345